Natco Pharma Ltd

NSE: NATCOPHARM · BSE: 524816 · Pharmaceuticals & Biotechnology · 18 announcements

Share price: ₹839.30
Market cap: ₹15,033 Cr
Revenue (annual): ₹4,078 Cr
Net profit (annual): ₹1,418 Cr
P/E (TTM): 13.1×Sector 50.4×
Promoter holding: 49.42%+0.00% QoQ
FII holding: 16.99%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Earnings Call 6 Capital Structure Change 3 Fund Raise 2 Financial Results 2 Board Meeting Date 2 Other Announcement 1 Annual Report 1 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

4 Sep 2026 20:16 IST NSE

Annual General Meeting

Natco Pharma Annual General Meeting

Natco Pharma issued the notice for its 43rd Annual General Meeting to be held on September 30, 2026, covering agenda items including director appointment and fund-raising.

Read the filing ↗